Published on October 13, 2017
Is the future getting brighter for patients living with multiple myeloma? What advances are on the horizon, and what population of patients will benefit? On Sunday, October 8, an online audience of myeloma patients and their caregivers joined virtually to learn about the evolving treatment landscape in the myeloma, including newer agents, breakthroughs for relapsed myeloma patients, and combination therapies that are making a big difference.
This virtual town meeting was sponsored by the Patient Empowerment Network, which received educational grants from AbbVie Inc. and Takeda Oncology. It was produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center.